-
Report Prologue
-
Executive Summary
-
Market Introduction
-
Scope of Study 25
-
Research Objective 25
-
List of Assumptions
-
Market Structure 26
-
Research Methodology
-
Primary
-
Research Methodology 29
-
Data points received from the Specialist Doctors:
-
Data points received from the Manufacturer/ Pharmaceutical Companies:
-
Data points received from Hospitals, Diagnostic Centers: 31
-
Secondary Research Methodology 32
-
Market Share Analysis 33
-
Trade
-
Analysis 34
-
Market Pricing Approach 34
-
Forecast Model 35
-
Market Dynamics
-
Introduction 37
-
Drivers 38
- Growing
-
number of stem cell, soft-tissue, and solid organ, transplantation procedures 38
-
Rising occurrence of chronic and infectious diseases 38
- Increasing
-
Awareness Related to Transplant Diagnostic Procedures 38
-
Restraints 39
- Shortage of donor organ and limited medical reimbursement 39
-
High cost of NGS- and PCR-based devices 39
-
Opportunities 40
-
High demand for tissue engineering in cosmetic and reconstructive surgery 40
-
Growing geriatric population presents a significant growth opportunity 40
-
Market Factor Analysis
-
Porters Five Forces Analysis 42
-
Bargaining Power of Suppliers 42
-
Bargaining Power of Buyers 43
-
Threat of New Entrants 43
-
Threat of Substitutes 43
- Intensity
-
of Rivalry 43
-
Supply Chain Analysis 44
- Primary activities 44
- Secondary Activities 45
-
Immunosuppressant Drug Monitoring (ISD)
-
Overview 47
-
Diagnostic Tests for Transplantation 47
- Therapeutic
-
Drug Monitoring During Transplantation 47
-
Americas 48
- North
-
America 48
-
U.S. 50
- Canada 51
- South America
-
Europe 53
- Germany 54
- U.K 55
- France
- Spain 57
- Italy 58
- Rest of Europe 59
-
Asia Pacific 61
-
China 62
- Japan 63
- India 64
-
Australia 65
-
Rest of Asia Pacific 66
-
Middle East & Africa
- Middle East 69
- Africa 70
-
Transplant Diagnostics
-
Market, By Products and Services
-
Introduction 73
- Instruments
- Reagents & Consumables 76
- Software and Services 76
-
Transplant Diagnostics Market, By Screening Type
-
Introduction
- Pre-Transplant Screening 79
- Post-Transplant Screening 79
-
Transplant Diagnostics Market, By Organ Type
-
Introduction 81
- Kidney 82
- Liver 82
- Heart 83
- Lung 83
- Pancreas 83
-
Transplant Diagnostics Market, By Application
-
Type
-
Introduction 85
- Research Applications 86
-
Diagnostic Applications 86
-
Transplant Diagnostics Market, By End User
-
Introduction 88
- Commercial Service Providers 89
- Hospitals
-
and Transplant Centres 89
-
Research Laboratories and Academic Institutes
-
Global Transplant Diagnostics Market, By Region
-
Introduction
-
Americas 92
-
Transplant Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market,
-
By Organ Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant
-
Diagnostics Market, By End User
-
North America 93
-
Transplant Diagnostics
-
Market, By Products and Services
-
Transplant Diagnostics Market, By Screening
-
Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics
-
Market, By Application Type
-
Transplant Diagnostics Market, By End User
-
U.S. 97
-
Transplant Diagnostics Market, By Products and Services
-
Transplant
-
Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market, By Organ
-
Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant Diagnostics
-
Market, By End User
-
Canada 100
-
Transplant Diagnostics Market,
-
By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics Market,
-
By Application Type
-
Transplant Diagnostics Market, By End User
-
South America 104
-
Transplant Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market,
-
By Organ Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant
-
Diagnostics Market, By End User
-
Europe 108
-
Transplant Diagnostics
-
Market, By Products and Services
-
Transplant Diagnostics Market, By Screening
-
Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics
-
Market, By Application Type
-
Transplant Diagnostics Market, By End User
-
Germany 112
-
Transplant Diagnostics Market, By Products and Services
-
Transplant
-
Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market, By Organ
-
Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant Diagnostics
-
Market, By End User
-
U.K 116
-
Transplant Diagnostics Market, By Products
-
and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant
-
Diagnostics Market, By Organ Type
-
Transplant Diagnostics Market, By Application
-
Type
-
Transplant Diagnostics Market, By End User
-
France 119
-
Transplant
-
Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market,
-
By Screening Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant
-
Diagnostics Market, By Application Type
-
Transplant Diagnostics Market, By End
-
User
-
Spain 123
-
Transplant Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market,
-
By Organ Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant
-
Diagnostics Market, By End User
-
Italy 126
-
Transplant Diagnostics
-
Market, By Products and Services
-
Transplant Diagnostics Market, By Screening
-
Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics
-
Market, By Application Type
-
Transplant Diagnostics Market, By End User
-
Rest of Europe 130
-
Transplant Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market,
-
By Organ Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant
-
Diagnostics Market, By End User
-
Asia Pacific 134
-
Transplant Diagnostics
-
Market, By Products and Services
-
Transplant Diagnostics Market, By Screening
-
Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics
-
Market, By Application Type
-
Transplant Diagnostics Market, By End User
-
China 138
-
Transplant Diagnostics Market, By Products and Services
-
Transplant
-
Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market, By Organ
-
Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant Diagnostics
-
Market, By End User
-
Japan 142
-
Transplant Diagnostics Market, By
-
Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant
-
Diagnostics Market, By Organ Type
-
Transplant Diagnostics Market, By Application
-
Type
-
Transplant Diagnostics Market, By End User
-
India 145
-
Transplant
-
Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market,
-
By Screening Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant
-
Diagnostics Market, By Application Type
-
Transplant Diagnostics Market, By End
-
User
-
Australia 149
-
Transplant Diagnostics Market, By Products and
-
Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics
-
Market, By Organ Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant Diagnostics Market, By End User
-
Rest of Asia Pacific 152
-
Transplant Diagnostics Market, By Products and Services
-
Transplant Diagnostics
-
Market, By Screening Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant
-
Diagnostics Market, By Application Type
-
Transplant Diagnostics Market, By End
-
User
-
Middle East & Africa 156
-
Transplant Diagnostics Market,
-
By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics Market,
-
By Application Type
-
Transplant Diagnostics Market, By End User
-
Middle East 160
-
Transplant Diagnostics Market, By Products and Services
-
Transplant Diagnostics Market, By Screening Type
-
Transplant Diagnostics Market,
-
By Organ Type
-
Transplant Diagnostics Market, By Application Type
-
Transplant
-
Diagnostics Market, By End User
-
Africa 164
-
Transplant Diagnostics
-
Market, By Products and Services
-
Transplant Diagnostics Market, By Screening
-
Type
-
Transplant Diagnostics Market, By Organ Type
-
Transplant Diagnostics
-
Market, By Application Type
-
Transplant Diagnostics Market, By End User
-
Competitive Landscape
-
Company Market Share Analysis 169
- Introduction
-
Competitive Landscape 170
- Introduction 170
-
Key
-
Developments 171
-
Company Profiles
-
Thermo Fisher Scientific
-
Inc. 175
-
Company Overview 175
- Financial Overview 175
- Products Offering 176
- Key Developments 176
- SWOT
-
Analysis 176
-
Key Strategy 177
-
Bio-Rad Laboratories, Inc. 178
- Company Overview 178
- Financial Overview 178
- Products
-
Offering 179
-
Key Developments 179
- SWOT Analysis 179
-
Key Strategy 180
-
F. Hoffmann-La Roche AG 181
- Company Overview
- Financial Overview 181
- Products Offering 182
-
Key Developments 182
-
SWOT Analysis 183
- Key Strategy 183
-
Qiagen N.V. 184
- Company Overview 184
- Financial Overview
- Products Offering 185
- Key Developments 185
-
SWOT Analysis 185
-
Key strategy 185
-
BioMérieux SA 186
- Company Overview 186
- Financial Overview 186
- Products
-
Offering 187
-
Key Developments 187
- SWOT Analysis 187
-
Key Strategy 187
-
Illumina, Inc. 188
- Company Overview 188
- Financial Overview 188
- Products Offering 189
- Key
-
Developments 189
-
SWOT Analysis 190
- Key Strategy 190
-
Becton, Dickinson and Company 191
-
Company Overview 191
- Financial
-
Overview 191
-
Products Offering 192
- Key Developments 192
- SWOT Analysis 192
- Key Strategy 193
-
Caredx, Inc. 194
- Company Overview 194
- Financial Overview 194
- Products
-
Offering 195
-
Key Developments 195
- SWOT Analysis 195
-
Key Strategy 196
-
Gendx 197
- Company Overview 197
-
Financial Overview 197
-
Products Offering 197
- Key Developments
- SWOT Analysis 198
- Key Strategy 198
-
Zimmer
-
Biomet 199
-
Company Overview 199
- Financial Overview 199
- Products Offering 200
- Key Developments 200
- SWOT
-
Analysis 200
-
Key Strategy 200
-
Medtronic PLC 201
-
Company Overview 201
-
Financial Overview 201
- Products Offering
- Key Developments 202
- SWOT Analysis 202
-
Key Strategy 202
-
DiaSorin S.P.A 203
- Company Overview 203
- Financial Overview 203
- Products Offering 204
-
Key Developments 204
-
SWOT Analysis 204
- Key Strategy 204
-
Merck KGaA 205
- Company Overview 205
- Financial
-
Overview 205
-
Products Offering 206
- Key Developments 206
- SWOT Analysis 206
- Key Strategy 207
-
Immucor, Inc.
- Company Overview 208
- Financial Overview: 208
-
Products Offering 208
-
Key Developments 208
- SWOT Analysis
- Key strategy 209
-
Appendix
-
Discussion Blue
-
Print 211
-
Reference 214
-
List of Tables
-
SYNOPSIS 22
-
(USD MILLION) 47
-
2027 (USD MILLION) 48
-
BY COUNTRY 2020-2027 (USD MILLION) 48
-
DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
-
2027 (USD MILLION) 48
-
DRUG
-
2027 (USD MILLION) 49
-
DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 49
-
IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD
-
MILLION) 50
-
DRUG 2020-2027 (USD MILLION) 50
-
MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 50
-
DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 51
-
CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
-
(USD MILLION) 51
-
BY TEST TYPE 2020-2027 (USD MILLION) 51
-
DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
-
2027 (USD MILLION) 52
-
DRUG
-
2027 (USD MILLION) 52
-
DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 52
-
TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 53
-
EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027
-
(USD MILLION) 53
-
BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 53
-
DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 54
-
IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD
-
MILLION) 54
-
DRUG 2020-2027 (USD MILLION) 54
-
MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 55
-
MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 55
-
DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 55
-
MILLION) 56
-
HLA TYPING 2020-2027 (USD MILLION) 56
-
MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 56
-
FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD
-
MILLION) 57
-
HLA TYPING 2020-2027 (USD MILLION) 57
-
MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 57
-
SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION)
-
TYPING 2020-2027 (USD MILLION) 58
-
MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 58
-
(USD MILLION) 58
-
ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION)
-
HLA TYPING
-
2027 (USD MILLION) 59
-
DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
-
2027 (USD MILLION) 59
-
2027 (USD MILLION) 60
-
BY COUNTRY 2020-2027 (USD MILLION) 61
-
DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 61
-
ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
-
2027 (USD MILLION) 61
-
MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 62
-
DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 62
-
CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
-
(USD MILLION) 62
-
TEST TYPE 2020-2027 (USD MILLION) 63
-
MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 63
-
JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
-
(USD MILLION) 63
-
TEST TYPE 2020-2027 (USD MILLION) 64
-
MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 64
-
INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
-
(USD MILLION) 64
-
TEST TYPE 2020-2027 (USD MILLION) 65
-
MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 65
-
AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
-
2027 (USD MILLION) 65
-
MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 66
-
DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 66
-
REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
-
2027 (USD MILLION) 66
-
MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 67
-
AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2020-2027 (USD MILLION)
-
BY MOLECULAR HLA TYPING
-
2027 (USD MILLION) 68
-
& AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
-
2027 (USD MILLION) 68
-
DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 69
-
EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027
-
(USD MILLION) 69
-
BY IMMUNOSUPPRESSANT DRUG
-
2027 (USD MILLION) 69
-
IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 70
-
2027 (USD MILLION) 70
-
MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 70
-
IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 71
-
(USD MILLION) 73
-
& CONSUMABLES 2020-2027 (USD MILLION) 74
-
MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 74
-
DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 74
-
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION)
-
2027 (USD MILLION) 75
-
INSTRUMENTS, BY REGION 2020-2027 (USD MILLION) 75
-
DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION 2020-2027 (USD MILLION)
-
BY REGION 2020-2027 (USD MILLION) 76
-
MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 78
-
DIAGNOSTICS MARKET FOR PRE-TRANSPLANT SCREENING, BY REGION 2020-2027 (USD MILLION)
-
BY REGION 2020-2027 (USD MILLION) 79
-
MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 81
-
DIAGNOSTICS MARKET FOR KIDNEY, BY REGION 2020-2027 (USD MILLION) 82
-
GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY REGION 2020-2027 (USD MILLION)
-
(USD MILLION) 83
-
REGION 2020-2027 (USD MILLION) 83
-
FOR PANCREAS, BY REGION 2020-2027 (USD MILLION) 83
-
DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 85
-
TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION)
-
BY REGION 2020-2027 (USD MILLION) 86
-
MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION 2020-2027 (USD MILLION) 86
-
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 88
-
BY REGION 2020-2027 (USD MILLION) 89
-
MARKET FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION
-
2027 (USD MILLION)
-
AND ACADEMIC INSTITUTES, BY REGION
-
2027 (USD MILLION) 89
-
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 91
-
AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 92
-
MILLION) 93
-
AND SERVICES 2020-2027 (USD MILLION) 93
-
DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 94
-
(USD MILLION) 94
-
MOLECULAR ASSAY 2020-2027 (USD MILLION) 94
-
DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 94
-
NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027
-
(USD MILLION) 95
-
SCREENING TYPE 2020-2027 (USD MILLION) 95
-
DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 95
-
AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 96
-
2027 (USD MILLION) 96
-
BY END USER 2020-2027 (USD MILLION) 96
-
MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 97
-
TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION)
-
(USD MILLION) 97
-
ASSAY 2020-2027 (USD MILLION) 97
-
BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 98
-
MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 98
-
TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 98
-
U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 99
-
2027 (USD MILLION) 99
-
END USER 2020-2027 (USD MILLION) 100
-
MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 100
-
TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION)
-
(USD MILLION) 101
-
ASSAY 2020-2027 (USD MILLION) 101
-
BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 101
-
DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 101
-
CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION)
-
(USD MILLION) 102
-
2027 (USD MILLION) 102
-
BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 103
-
DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 103
-
AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION)
-
CONSUMABLES 2020-2027 (USD MILLION) 104
-
DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 104
-
SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION)
-
2027 (USD MILLION) 105
-
MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 105
-
AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION)
-
(USD MILLION) 106
-
APPLICATION 2020-2027 (USD MILLION) 106
-
DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 106
-
SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION)
-
MILLION) 108
-
SERVICES 2020-2027 (USD MILLION) 109
-
MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 109
-
EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION)
-
(USD MILLION) 109
-
ASSAY 2020-2027 (USD MILLION) 110
-
BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 110
-
DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 110
-
EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 111
-
MILLION) 111
-
APPLICATIONS 2020-2027 (USD MILLION) 111
-
MARKET, BY END USER 2020-2027 (USD MILLION) 112
-
DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 112
-
GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027
-
(USD MILLION) 112
-
& KITS 2020-2027 (USD MILLION) 113
-
MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 113
-
DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 113
-
GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD
-
MILLION) 113
-
TYPE 2020-2027 (USD MILLION) 114
-
BY ORGAN TYPE 2020-2027 (USD MILLION) 114
-
MARKET, BY APPLICATION 2020-2027 (USD MILLION) 114
-
DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 115
-
GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 115
-
(USD MILLION) 116
-
& CONSUMABLES 2020-2027 (USD MILLION) 116
-
MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 116
-
DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 116
-
U.K TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 117
-
(USD MILLION) 117
-
TYPE 2020-2027 (USD MILLION) 117
-
BY ORGAN TYPE 2020-2027 (USD MILLION) 118
-
MARKET, BY APPLICATION 2020-2027 (USD MILLION) 118
-
DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 118
-
U.K TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 119
-
(USD MILLION) 119
-
& CONSUMABLES 2020-2027 (USD MILLION) 119
-
MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 120
-
DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 120
-
FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION)
-
2027 (USD MILLION) 120
-
BY SCREENING TYPE 2020-2027 (USD MILLION) 121
-
MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 121
-
DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 121
-
TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (U